Skip to main content
. 2020 May 1;12:3045–3051. doi: 10.2147/CMAR.S244806

Table 3.

Associations Between Node-Specific Features and Incidence of Miss-Detection by Radioisotope and Blue Dye, Respectively

Variable Overall (n=2382) SLNs Detected by Radioisotope (n=1984) SLNs Missed by Radioisotope (n=398) p-value SLNs Detected by Blue Dye (n=1641) SLNs Missed by Blue Dye (n=741) p-value
Size of lymph node (mean ± SD) (mm) 10.68 ± 7.34 11.16 ± 7.47 8.28 ± 6.11 <0.001* 11.41 ± 7.72 9.02 ± 6.07 <0.001*
Involvement of lymph node 0.014* <0.001*
Negative 2003 (84.1%) 1652 (83.3%) 351 (86.9%) 1347 (82.1%) 656 (88.5%)
Positive 379 (15.9%) 332 (16.7%) 47 (13.1%) 294 (17.9%) 85 (11.5%)
Location of lymph node 0.337 <0.001*
Level I 2169 (91.1%) 1803 (90.9%) 366 (92.0%) 1548 (94.3%) 621 (83.8%)
Level II~IIIa 197 (8.3%) 169 (8.5%) 28 (7.0%) 81 (4.9%) 116 (15.7%)
Injection site 0.241
Tumor site 1941 (81.5%) 1305 (79.5%) 636 (85.8%)
Periareolar 55 (2.3%) 40 (2.4%) 15 (2.0%)
Tumor site and periareolar 52 (2.2%) 40 (2.4%) 12 (1.6%)

Notes: aOnly one SLN of level III was detected; *p<0.05.

Abbreviations: SD, standard deviation; SLNs, sentinel lymph nodes.